- Main
DNA methylation study of Huntington’s disease and motor progression in patients and in animal models
- Lu, Ake T;
- Narayan, Pritika;
- Grant, Matthew J;
- Langfelder, Peter;
- Wang, Nan;
- Kwak, Seung;
- Wilkinson, Hilary;
- Chen, Richard Z;
- Chen, Jian;
- Simon Bawden, C;
- Rudiger, Skye R;
- Ciosi, Marc;
- Chatzi, Afroditi;
- Maxwell, Alastair;
- Hore, Timothy A;
- Aaronson, Jeff;
- Rosinski, Jim;
- Preiss, Alicia;
- Vogt, Thomas F;
- Coppola, Giovanni;
- Monckton, Darren;
- Snell, Russell G;
- William Yang, X;
- Horvath, Steve
- et al.
Published Web Location
https://doi.org/10.1038/s41467-020-18255-5Abstract
Although Huntington's disease (HD) is a well studied Mendelian genetic disorder, less is known about its associated epigenetic changes. Here, we characterize DNA methylation levels in six different tissues from 3 species: a mouse huntingtin (Htt) gene knock-in model, a transgenic HTT sheep model, and humans. Our epigenome-wide association study (EWAS) of human blood reveals that HD mutation status is significantly (p < 10-7) associated with 33 CpG sites, including the HTT gene (p = 6.5 × 10-26). These Htt/HTT associations were replicated in the Q175 Htt knock-in mouse model (p = 6.0 × 10-8) and in the transgenic sheep model (p = 2.4 × 10-88). We define a measure of HD motor score progression among manifest HD cases based on multiple clinical assessments. EWAS of motor progression in manifest HD cases exhibits significant (p < 10-7) associations with methylation levels at three loci: near PEX14 (p = 9.3 × 10-9), GRIK4 (p = 3.0 × 10-8), and COX4I2 (p = 6.5 × 10-8). We conclude that HD is accompanied by profound changes of DNA methylation levels in three mammalian species.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-